Sensus Healthcare (SRTS) Surges 7.9%: Is This an Indication of Further Gains?

Sensus Healthcare, Inc. SRTS shares ended the last trading session 7.9% higher at $7.34. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 20.9% loss over the past four weeks.Sensus Healthcare scored a strong price increase driven by the optimism surrounding the company’s announcement of third-quarter 2024 results. The company reported quarterly earnings of 7 cents per share, which beat the Zacks Consensus Estimate of a loss of 2 cents per share by 450%. Also, the company’s third-quarter revenue surpassed the estimates by 51.3%. This company is expected to post quarterly earnings of $0.10 per share in its upcoming report, which represents a year-over-year change of -61.5%. Revenues are expected to be $9.86 million, down 21.6% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For Sensus Healthcare, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on SRTS going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Sensus Healthcare belongs to the Zacks Medical - Instruments industry. Another stock from the same industry, DexCom DXCM, closed the last trading session 0.4% higher at $80.57. Over the past month, DXCM has returned 2.7%.For DexCom, the consensus EPS estimate for the upcoming report has changed -0.2% over the past month to $0.52. This represents a change of +4% from what the company reported a year ago. DexCom currently has a Zacks Rank of #3 (Hold).Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sensus Healthcare, Inc. (SRTS): Free Stock Analysis Report DexCom, Inc. (DXCM): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks